|
|
|
|
Vol. 18, Issue 12, 5048-5059, December 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
,
,||
,
,
*Institut National de la Santé et de la Recherche Médicale U563, Toulouse, F-31000, France;
Institut Claudius Regaud, Toulouse, F-31052, France;
Université Toulouse III Paul Sabatier, Toulouse, F-31000, France; ¶Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, K1H 8L1, Canada; and #Laboratoire de Virologie et Pathologie Humaine, Centre National de la Recherche Scientifique FRE 3011, Université Claude Bernard Lyon 1, Faculté de Médecine RTH Laënnec, F-69372 Lyon, France
Submitted June 25, 2007;
Revised September 7, 2007;
Accepted September 14, 2007
Monitoring Editor: Marvin P. Wickens
Heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is a nucleocytoplasmic shuttling protein that regulates gene expression through its action on mRNA metabolism and translation. The cytoplasmic redistribution of hnRNP A1 is a regulated process during viral infection and cellular stress. Here, we show that hnRNP A1 is an internal ribosome entry site (IRES) trans-acting factor that binds specifically to the 5' untranslated region of both the human rhinovirus-2 and the human apoptotic peptidase activating factor 1 (apaf-1) mRNAs, thereby regulating their translation. Furthermore, the cytoplasmic redistribution of hnRNP A1 after rhinovirus infection leads to enhanced rhinovirus IRES-mediated translation, whereas the cytoplasmic relocalization of hnRNP A1 after UVC irradiation limits the UVC-triggered translational activation of the apaf-1 IRES. Therefore, this study provides a direct demonstration that IRESs behave as translational enhancer elements regulated by specific trans-acting mRNA binding proteins in given physiological conditions. Our data highlight a new way to regulate protein synthesis in eukaryotes through the subcellular relocalization of a nuclear mRNA-binding protein.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
These authors contributed equally to this work.
|| Present address: Parc de Recerca Biomèdica de Barcelona (PRBB), Centre de Regulació Genòmica (CRG) c/ Dr. Aiguader, 88, Planta 6, 08003 Barcelona, Spain.
Address correspondence to: Stéphan Vagner (vagner{at}toulouse.inserm.fr).